4.0 Conclusion of the Oral Delivery of Therapeutic Proteins and Peptides Research
The as implied in the preliminary facets of this paper, the intention of the researcher is to explore various strategies for improving the bioavailability of therapeutic protein and peptide. This premise is purposed to propose a systematic endeavour to identify he various factors that prevent the absorption of peptides and proteins across the gastrointestinal lining, and well-founded strategies of improving the bioavailability of these types of drugs. The proposed is geared to pursue this research purpose by exploring relevant literature pieces that touch on relevant topics including the mechanisms of drug absorption in the gastrointestinal tract, barriers to oral administration of protein and peptide drugs, and strategies to augment the delivery of peptide and protein drugs.
Aluko, R. E. (2012). Functional foods and nutraceuticals. New York, NY, Springer. http://dx.doi.org/10.1007/978-1-4614-3480-1.
Anderle, P. (2009). Kinetics and pathways of intestinal absorption and enzymatic cleavage of therapeutic proteins upon peroral delivery. S.l, s.n.].
Baechler, B. (2014). Investigation of the role of Hindsight in the development of the Drosophila midgut. Thesis (M.Sc.)–University of Waterloo, 2014.
Douroumis, D., & Fahr, A. (2012). Drug delivery strategies for poorly water-soluble drugs. Chichester, West Sussex, John Wiley & Sons. http://public.eblib.com/choice/publicfullrecord.aspx?p=1116228.
Fox, R. (2009). Investigation of the absorption pathways of some poorly absorbed drugs using human intestinal (Caco-2) cell monolayers. Aston University. http://eprints.aston.ac.uk/10959/.
Gaginella, T. S., Mozsik, G., & Rainsford, K. D. (2007). Biochemical Pharmacology as an Approach to Gastrointestinal Disorders Basic Science to Clinical Perspectives (2006). Dordrecht, Springer Netherlands. http://dx.doi.org/10.1007/978-94-011-5390-4.
Grundy, D., & Brookes, S. (2012). Neural control of gastrointestinal function. San Rafael, Calif, Morgan & Claypool Life Sciences. http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=440524.
Hart, C. L., & Ksir, C. (2011). Drugs, society, & human behavior. New York, McGraw-Hill.
Herkenne, C. (2005). Evaluation and optimization of topical drug bioavailability. Geneve, [s.n.]. Herkenne (2005, p. 133)
Hernandez, M. A., & Rathinavelu, A. (2006). Basic pharmacology: understanding drug actions and reactions. Boca Raton, CRC, Taylor & Francis.
Jeffrey, P. (2001). The influence of absorption and gut wall metabolism on drug bioavailability. University of Sheffield. Jeffrey (2001).
Johnson, L. R., & Byrne, J. H. (2003). Essential medical physiology. Amsterdam, Elsevier Academic Press. http://www.123library.org/book_details/?id=42761.
Krishna, R., & Yu, L. (2007). Biopharmaceutics applications in drug development. Springer E-Books. New York, Springer.
Mcclements, D. J., & Decker, E. (2009). Designing functional foods: measuring and controlling food structure breakdown and nutrient absorption. http://public.eblib.com/choice/publicfullrecord.aspx?p=1639830
Menon, S. S. (2004). Mechanistic modeling approaches to time-dependent oral drug absorption. Dissertation Abstracts International. 65-02. Thesis (Ph. D.)–University of Michigan, 2004. Menon (2004, p. 31)
Whitney, E. N., & Rolfes, S. R. (2011). Understanding nutrition. Australia, Wadsworth, Cengage Learning.